The pharmaceutical industry could have been better prepared for the COVID-19 pandemic. What did they learn that will help them respond better in the future?

In this roundtable, three thought leaders detail the barriers in the way of digital transformation and outline their vision for the future.

How can pharma transform its approach to patients by introducing digital platforms and virtual care into their spaces?

How can AI help MA retain their human touch as the industry reimagines the field and creates a best-in-class function?

Diversity and inclusion (D&I) has become a core focus for pharma, but how can it go one step further and cultivate a culture of belonging?

we look at how AI tools can boost traditional marketing campaigns’ productivity, improve targeting, and deliver significant business value.

In what ways can we hold each other accountable, not just for the number of women in leadership, but how women, and especially women of colour, are represented and supported throughout the hiring pipeline?

After years of tough negotiations, the UK has left the European Union. GOLD explores how pharmaceutical innovation has been affected as the UK works to replace EU resources and make use of its new-found regulatory freedom